Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350g variant

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 4, 2006, Pages 820-822

  Grodzki, Martha ^a   Besson, Guillaume ^b   Clavel, Christine ^b   Arslan, Annie ^c   Franceschi, Silvia ^c   Birembaut, Philippe ^b   Tommasino, Massimo ^c   Zehbe, Ingeborg ^d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HÔPITAL MAISON BLANCHE   (France)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX DISEASE; VIRUS INFECTION;

CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FRANCE; HUMANS; ODDS RATIO; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33646227439     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0864     Document Type: Article

References (36)

1. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
2. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-5.
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
4. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005;32 Suppl 1:S16-24.
5. Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002;3:11-6.
6. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005;337:76-84.
7. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072-9.
8. Castle PE, Solomon D, Schiffman M, et al. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 2005;97:1066-71.
9. Seedorf K, Krammer G, Durst M, et al. Human papillomavirus 16 DNA sequence. Virology 1985;145:181-5.
10. Bernard HU, Calleja-Macias IE, et al. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006;118:1071-6.
11. Zehbe I, Tommasino M. The biological significance of human papillomavirus 16 variants for the development of cervical neoplasia. Papillomavirus Report 1999;10:105-16.
12. Chen Z, Terai M, Fu L, et al. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 2005;79:7014-23.
13. Del Refugio Gonzalez-Losa M, Laviada Mier y Teran MA, et al. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol 2004;29:95-8.
14. Chaturvedi AK, Brinkman JA, Gaffga AM, et al. Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J Gen Virol 2004;85:1237-41.
15. Picconi MA, Alonio LV, Sichero L, et al. Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J Med Virol 2003;69:546-52.
16. Sathish N, Abraham P, Peedicayil A, et al. HPV16 E6 sequence variations in Indian patients with cervical neoplasia. Cancer Lett 2005;229:93-9.
17. Da Costa MM, Hogeboom CJ, Holley EA, et al. Increased risk of high-grade neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 2002;185:1229-37.
18. Radhakrishna Pillai M, Sreevidya S, Pollock BH, Jayaprakash PG, Herman B. Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. Gynecol Oncol 2002;87:268-73.
19. Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81:2959-68.
20. Berumen J, Ordonez RM, Lazcano E, et al. Asian-American Variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001;93:1325-30.
21. Xi LF, Carter JJ, Galloway DA, et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 2002;11:343-51.
22. Xi LF, Koutski LA, Galloway DA, et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997;89:796-802.
23. Zehbe I, Wilander E, Delius H, et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998;58:829-33.
24. Zehbe I, Voglino G, Delius H, et al. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998;352:1441-3.
25. Zehbe I, Tachezy R, Mytilineos J, et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 2001;94:711-6.
26. Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84:1616-23.
27. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-4272.
28. Chan PK, Lam CW, Cheung TH, et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 2002;186:696-700.
29. Kang S, Jeon YT, Kim JW, et al. Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Int J Gynecol Cancer 2005;15:107-12.
30. Vaeteewoottacharn K, Jearnanaikoon P, Ponglikitmongkol M. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas. Anticancer Res 2003;23:1927-1031.
31. Zehbe I, Mytilineos J, Wikstrom I, et al. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum Immunol 2003;64:538-42.
32. Carrington M, Wang S, Martin MP, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 2005;201:1069-75.
33. Arias-Pulido H, Joste N, Wheeler CM. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinoma carrying the DRB1*1501-DQB1*0602 haplotype. Genes Chromosomes Cancer 2004;40:277-84.
34. Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001;20:7874-87.
35. Stoppler MC, Ching K, Stoppler H, et al. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 1996;70:6987-93.
36. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, et al. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol 2004;78:5934-45.